Valuation: ResMed, Inc.

Market Cap 2.93TCr 2.57TCr 2.39TCr 2.2TCr 4.13TCr 2,79800Cr 4.2TCr 28TCr 11TCr 1,38800Cr 11TCr 11TCr 4,79500Cr P/E 2026 *
19.2x
P/E 2027 * 17.9x
Enterprise Value 2.85TCr 2.5TCr 2.33TCr 2.14TCr 4.01TCr 2,71900Cr 4.08TCr 28TCr 11TCr 1,34900Cr 11TCr 10TCr 4,66000Cr EV / Sales 2026 *
5.04x
EV / Sales 2027 * 4.63x
Free-Float
75.61%
Yield 2026 *
1.2%
Yield 2027 * 1.29%
1 day+2.76%
1 week+6.27%
Current month+6.77%
1 month+4.86%
3 months-4.17%
6 months-19.26%
Current year-13.62%
1 week 190.21
Extreme 190.21
210.11
1 month 190.21
Extreme 190.21
222.43
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/07/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
08/06/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
01/06/26 Tax

General Counsel

-269 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+2.76%+6.27%-23.92%-6.76% 2.93TCr
+1.80%+9.13%+17.79%+1.67% 21TCr
+1.59%+10.98%-2.10%-23.61% 14TCr
+2.47%+4.42%-26.00%+11.94% 13TCr
+2.14%+7.54%-56.12%-10.15% 6.76TCr
+0.82%-0.77%+6.89%+0.19% 4.78TCr
+1.01%+4.09%-24.96%-31.74% 4.5TCr
+1.21%+5.01%+16.71%+10.68% 3.89TCr
+2.79%+3.71%+26.07%+33.39% 3.64TCr
+1.16%-0.27%+74.75%-0.22% 2.87TCr
Average +1.76%+1.32%+0.91%-1.46% 7.66TCr
Weighted average by Cap. +1.81%+1.49%-1.85%-2.72%

Financials

2026 *2027 *
Net sales 565.06Cr 495.89Cr 461.78Cr 424.73Cr 796.19Cr 54TCr 809.84Cr 5.48TCr 2.14TCr 27TCr 2.12TCr 2.08TCr 92TCr 596.78Cr 523.73Cr 487.7Cr 448.57Cr 840.88Cr 57TCr 855.3Cr 5.79TCr 2.26TCr 28TCr 2.24TCr 2.19TCr 98TCr
Net income 154.63Cr 135.7Cr 126.37Cr 116.23Cr 217.88Cr 15TCr 221.62Cr 1.5TCr 586.81Cr 7.33TCr 580.52Cr 567.98Cr 25TCr 161.15Cr 141.43Cr 131.7Cr 121.13Cr 227.07Cr 15TCr 230.96Cr 1.56TCr 611.55Cr 7.64TCr 605Cr 591.93Cr 26TCr
Net Debt -83Cr -73Cr -68Cr -62Cr -116.48Cr -7.9TCr -118.48Cr -801.46Cr -313.7Cr -3.92TCr -310.34Cr -303.64Cr -14TCr -164.65Cr -144.5Cr -134.56Cr -123.76Cr -232Cr -16TCr -235.98Cr -1.6TCr -624.85Cr -7.8TCr -618.14Cr -604.79Cr -27TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
28/26/28 $208.25 +2.55% 4,49,162
27/26/27 $203.08 +4.00% 11,42,770
24/26/24 $195.27 +1.76% 10,05,232
23/26/23 $191.89 -0.53% 10,12,467
22/26/22 $192.91 -1.48% 9,71,174
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
203.08USD
Average target price
248.60USD
Spread / Average Target
+22.41%

Quarterly revenue - Rate of surprise